MedTrace Logo

NHF vs. COT in Hypoxemic Pandemic Viral Illness

NCT04750408 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-03-31

No results posted yet for this study

Summary

The study compares oxygen and NHF in patients with acute viral illness. The duration will be 72h. After them physiological parameters and the outcome will be evaluated.

Conditions

  • Acute Viral Bronchitis
  • Hypoxemic Respiratory Failure
  • Hypercapnic Respiratory Failure

Interventions

DEVICE

Standard oxygen

COT describes the application of low-flow oxygen in any way (Hudson mask, nasal prongs,...).

DEVICE

Nasal high-flow

F is combination of room air supplemented with oxygen can be better patients. This gas mixture will be provided to the patient with a specialized nasal prong.

Sponsors & Collaborators

  • Jens Bräunlich

    lead OTHER

Principal Investigators

  • Jens Bräunlich, MD · chair

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2022-06-22
Completion
2022-06-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750408 on ClinicalTrials.gov